Frazer Lowe

782 total citations
25 papers, 598 citations indexed

About

Frazer Lowe is a scholar working on Physiology, Health, Toxicology and Mutagenesis and Molecular Biology. According to data from OpenAlex, Frazer Lowe has authored 25 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 11 papers in Health, Toxicology and Mutagenesis and 8 papers in Molecular Biology. Recurrent topics in Frazer Lowe's work include Smoking Behavior and Cessation (11 papers), Air Quality and Health Impacts (10 papers) and Carcinogens and Genotoxicity Assessment (6 papers). Frazer Lowe is often cited by papers focused on Smoking Behavior and Cessation (11 papers), Air Quality and Health Impacts (10 papers) and Carcinogens and Genotoxicity Assessment (6 papers). Frazer Lowe collaborates with scholars based in United Kingdom, Italy and Switzerland. Frazer Lowe's co-authors include Damien Breheny, Evan O. Gregg, Marianna Gaça, Michael McEwan, Tomasz Jaunky, Karsta Luettich, Tony Carr, Linsey E. Haswell, Ian M. Fearon and Christopher Proctor and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Molecular Cancer.

In The Last Decade

Frazer Lowe

25 papers receiving 567 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frazer Lowe United Kingdom 16 304 195 154 110 82 25 598
Andrew W. Caliri United States 6 126 0.4× 63 0.3× 197 1.3× 71 0.6× 69 0.8× 7 554
Mao-wen Weng United States 8 171 0.6× 101 0.5× 224 1.5× 125 1.1× 51 0.6× 8 537
Melania Assedi Italy 14 157 0.5× 62 0.3× 140 0.9× 51 0.5× 115 1.4× 37 786
Linda Schwartz United States 12 82 0.3× 119 0.6× 88 0.6× 200 1.8× 55 0.7× 17 574
Jingzhu Wang United States 11 225 0.7× 66 0.3× 110 0.7× 57 0.5× 31 0.4× 29 392
James E. Keating United States 9 221 0.7× 102 0.5× 92 0.6× 26 0.2× 68 0.8× 12 432
Jaideep Honavar United States 15 102 0.3× 45 0.2× 124 0.8× 22 0.2× 89 1.1× 19 479
Athanasios Kondylis Switzerland 13 169 0.6× 142 0.7× 105 0.7× 65 0.6× 69 0.8× 23 380
Martino Recchia Italy 10 90 0.3× 84 0.4× 120 0.8× 80 0.7× 65 0.8× 20 445
João Eduardo Nunes Salles Brazil 16 410 1.3× 58 0.3× 272 1.8× 16 0.1× 36 0.4× 39 937

Countries citing papers authored by Frazer Lowe

Since Specialization
Citations

This map shows the geographic impact of Frazer Lowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frazer Lowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frazer Lowe more than expected).

Fields of papers citing papers by Frazer Lowe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frazer Lowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frazer Lowe. The network helps show where Frazer Lowe may publish in the future.

Co-authorship network of co-authors of Frazer Lowe

This figure shows the co-authorship network connecting the top 25 collaborators of Frazer Lowe. A scholar is included among the top collaborators of Frazer Lowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frazer Lowe. Frazer Lowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brux, Melanie, Anja Hofmann, Frazer Lowe, et al.. (2023). Comparative study of the effects of cigarette smoke versus next-generation tobacco and nicotine product extracts on inflammatory biomarkers of human monocytes. Pflügers Archiv - European Journal of Physiology. 475(7). 823–833. 10 indexed citations
2.
Hofmann, Anja, Melanie Brux, Frazer Lowe, et al.. (2021). Comparative study of the effects of cigarette smoke versus next generation tobacco and nicotine product extracts on endothelial function. Redox Biology. 47. 102150–102150. 30 indexed citations
3.
Smith, Gina A., et al.. (2021). Impact of cigarette versus electronic cigarette aerosol conditioned media on aortic endothelial cells in a microfluidic cardiovascular model. Scientific Reports. 11(1). 4747–4747. 8 indexed citations
4.
Luettich, Karsta, Monita Sharma, Hasmik Yepiskoposyan, Damien Breheny, & Frazer Lowe. (2021). An Adverse Outcome Pathway for Decreased Lung Function Focusing on Mechanisms of Impaired Mucociliary Clearance Following Inhalation Exposure. SHILAP Revista de lepidopterología. 3. 750254–750254. 15 indexed citations
5.
Lowe, Frazer, Oscar M. Camacho, Nathan Gale, et al.. (2019). Evaluating the effects of switching from cigarette smoking to using a heated tobacco product on health effect indicators in healthy subjects: study protocol for a randomized controlled trial. Internal and Emergency Medicine. 14(6). 885–898. 20 indexed citations
8.
9.
Luettich, Karsta, Marja Talikka, Frazer Lowe, et al.. (2017). The Adverse Outcome Pathway for Oxidative Stress-Mediated EGFR Activation Leading to Decreased Lung Function. 3(1). 99–109. 18 indexed citations
10.
Breheny, Damien, Jason Adamson, David Azzopardi, et al.. (2017). A novel hybrid tobacco product that delivers a tobacco flavour note with vapour aerosol (Part 2): In vitro biological assessment and comparison with different tobacco-heating products. Food and Chemical Toxicology. 106(Pt A). 533–546. 28 indexed citations
11.
Murphy, James J., Marianna Gaça, Frazer Lowe, et al.. (2017). Assessing modified risk tobacco and nicotine products: Description of the scientific framework and assessment of a closed modular electronic cigarette. Regulatory Toxicology and Pharmacology. 90. 342–357. 54 indexed citations
12.
Jaunky, Tomasz, Katherine Hewitt, Damien Breheny, et al.. (2017). A comparative assessment of e-cigarette aerosols and cigarette smoke on in vitro endothelial cell migration. Toxicology Letters. 277. 123–128. 50 indexed citations
13.
Carr, Tony, et al.. (2016). E-cigarette aerosols induce lower oxidative stress in vitro when compared to tobacco smoke. Toxicology Mechanisms and Methods. 26(6). 465–476. 92 indexed citations
14.
Lowe, Frazer, et al.. (2014). A novel autoantibody test for the detection of pre-neoplastic lung lesions. Molecular Cancer. 13(1). 78–78. 15 indexed citations
15.
Lowe, Frazer, Karsta Luettich, & Evan O. Gregg. (2013). Lung cancer biomarkers for the assessment of modified risk tobacco products: an oxidative stress perspective. Biomarkers. 18(3). 183–195. 30 indexed citations
16.
Lowe, Frazer, Evan O. Gregg, & Michael McEwan. (2009). Evaluation of biomarkers of exposure and potential harm in smokers, former smokers and never-smokers. Clinical Chemistry and Laboratory Medicine (CCLM). 47(3). 311–20. 48 indexed citations
17.
Calapai, Gioacchino, Achille P. Caputi, Carmen Mannucci, et al.. (2009). Cardiovascular Biomarkers in Groups of Established Smokers after a Decade of Smoking. Basic & Clinical Pharmacology & Toxicology. 104(4). 322–328. 33 indexed citations
18.
Calapai, Gioacchino, Achille P. Caputi, Carmen Mannucci, et al.. (2009). A cross-sectional investigation of biomarkers of risk after a decade of smoking. Inhalation Toxicology. 21(13). 1138–1143. 28 indexed citations
19.
Izzo, Raffaele, Gianfranco Di Renzo, Nicola De Luca, et al.. (2008). Smoking Selectively Accelerates Carotid Atherosclerosis in Hypertensive Patients. High Blood Pressure & Cardiovascular Prevention. 15(4). 269–273. 2 indexed citations
20.
Gregg, Evan O., Alfred L. Fisher, Frazer Lowe, Michael McEwan, & Eian D. Massey. (2006). An approach to the validation of biomarkers of harm for use in a tobacco context. Regulatory Toxicology and Pharmacology. 44(3). 262–267. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026